Bio-Rad Laboratories Return on Tangible Equity 2010-2022 | BIO.B

Current and historical return on tangible equity values for Bio-Rad Laboratories (BIO.B) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Bio-Rad Laboratories Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2022-03-31 $-0.10B $9.59B -0.84%
2021-12-31 $4.25B $13.07B 34.53%
2021-09-30 $6.66B $14.86B 58.54%
2021-06-30 $4.05B $11.12B 41.53%
2021-03-31 $4.10B $10.13B 47.24%
2020-12-31 $3.81B $9.39B 49.98%
2020-09-30 $3.52B $8.33B 53.30%
2020-06-30 $1.95B $6.85B 34.13%
2020-03-31 $1.58B $5.89B 29.96%
2019-12-31 $1.76B $5.35B 35.73%
2019-09-30 $0.38B $4.72B 8.35%
2019-06-30 $0.90B $5.12B 20.62%
2019-03-31 $0.57B $4.49B 13.98%
2018-12-31 $0.37B $3.67B 9.30%
2018-09-30 $1.28B $4.25B 35.75%
2018-06-30 $1.03B $3.98B 33.80%
2018-03-31 $0.77B $3.81B 29.78%
2017-12-31 $0.12B $2.25B 5.75%
2017-09-30 $0.02B $2.15B 0.78%
2017-06-30 $0.01B $2.10B 0.60%
2017-03-31 $0.03B $2.00B 1.28%
2016-12-31 $0.03B $1.94B 1.32%
2016-09-30 $0.09B $1.98B 5.06%
2016-06-30 $0.09B $1.88B 5.20%
2016-03-31 $0.10B $1.79B 5.99%
2015-12-31 $0.11B $1.78B 6.67%
2015-09-30 $0.10B $1.70B 6.59%
2015-06-30 $0.10B $1.61B 6.60%
2015-03-31 $0.10B $1.45B 7.10%
2014-12-31 $0.09B $1.43B 6.32%
2014-09-30 $0.08B $1.39B 5.71%
2014-06-30 $0.06B $1.42B 4.42%
2014-03-31 $0.07B $1.46B 4.74%
2013-12-31 $0.08B $1.40B 5.92%
2013-09-30 $0.09B $1.33B 7.10%
2013-06-30 $0.14B $1.29B 11.35%
2013-03-31 $0.15B $1.24B 12.77%
2012-12-31 $0.17B $1.26B 14.09%
2012-09-30 $0.18B $1.18B 16.40%
2012-06-30 $0.19B $1.15B 16.80%
2012-03-31 $0.18B $1.10B 16.12%
2011-12-31 $0.18B $1.02B 16.52%
2011-09-30 $0.19B $1.14B 17.43%
2011-06-30 $0.19B $1.13B 18.51%
2011-03-31 $0.18B $1.05B 20.10%
2010-12-31 $0.19B $0.97B 22.09%
2010-09-30 $0.16B $0.87B 19.86%
2010-06-30 $0.15B $0.77B 20.30%
2010-03-31 $0.15B $0.75B 21.61%
2009-12-31 $0.15B $0.75B 22.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.907B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00